摘要
目的:探讨给予慢性支气管炎患者规范呼吸内科治疗的临床效果。方法:于2016年5月-2017年6月笔者所在医院收治的慢性支气管炎患者中随机选取82例作为对象,按照随机抽签法将其分为常规组(常规抗感染治疗,n=41)和观察组(规范化呼吸内科治疗,n=41),比较两组疗效。结果:观察组治疗总有效率、满意度分别为95.12%、97.65%,高于对照组的78.05%、80.49%,比较差异均有统计学意义(P<0.05);观察组不良反应发生率为2.44%,低于对照组的14.63%,平均住院时间短于对照组,比较差异均有统计学意义(P<0.05)。结论:给予慢性支气管炎患者规范化内科治疗,总体疗效更为确切。
Objective：To explore the clinical effects of standardized respiratory medicine treatment for patients with chronic bronchitis.Method：From May 2016 to June 2017,a total of 82 patients with chronic bronchitis admitted to the author＇s hospital were randomly selected as subjects.Patients were divided into normal group（Routine anti-infection treatment,n=41） and observation group（Standardization of respiratory medicine treatment,n=41） according to the random drawing method,the curative effects of the two groups were compared.Result：The total effective rate and satisfaction rate of the observation group were 95.12% and 97.65% respectively,higher than 78.05% and 80.49% of the control group,and the differences were statistically significant（P〈0.05）.The incidence of adverse reactions in the observation group was 2.44%,lower than 14.63% in the control group,and the average hospitalization time was shorter than that in the control group,and the differences were statistically significant（P〈0.05）.Conclusion：Given the standardized medical treatment for patients with chronic bronchitis,the overall efficacy is more accurate.
作者
熊新华
XIONG Xinhua(Duodao People’s Hospital in Jingmen City,Jingmen 448000,Chin)
出处
《中外医学研究》
2018年第13期30-32,共3页
CHINESE AND FOREIGN MEDICAL RESEARCH
关键词
慢性支气管炎
呼吸内科
治疗
Chronic bronchitis
Respiratory medicine
Treatment
